Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F7 | P08709 | 19/20 | 0.66 |
| ▸ | F2 | P00734 | 11/20 | 0.66 |
| ▸ | F10 | P00742 | 2/20 | 0.58 |
| ▸ | GPR139 | Q6DWJ6 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4958048 | 1.00 | F7 (0.66) | F7F2F10GPR139 | |
| SCHEMBL4959775 | 1.00 | F7 (0.66) | F7F2F10GPR139 | |
| SCHEMBL13936380 | 0.90 | F7 (0.56) | F7F2F10GPR139 | |
| SCHEMBL3871293 | 0.90 | F7 (0.56) | F7F2F10GPR139 | |
| SCHEMBL3862743 | 0.90 | F7 (0.56) | F7F2F10GPR139 | |
| SCHEMBL4961418 | 0.86 | F7 (0.70) | F7F2F10GPR139 | |
| SCHEMBL4956873 | 0.86 | F7 (0.70) | F7F2F10GPR139 | |
| SCHEMBL4956858 | 0.86 | F7 (0.70) | F7F2F10GPR139 | |
| SCHEMBL4960233 | 0.86 | F7 (0.50) | F7F2F10 | |
| SCHEMBL4961032 | 0.86 | F7 (0.50) | F7F2F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080312161-A1 | Compounds For Stabilizing Factor VII Polypeptide Formulations | NOVO NORDISK HEALTH CARE AG (CH) | 2008-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080312161-A1 | Compounds For Stabilizing Factor VII Polypeptide Formulations | F7, F5, F13B | F7 1/4885F2 14/4885F10 16/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.